Solitron Devices Reports Strong Q3 Performance and 124% Backlog Growth Amidst YTD Profitability Decline and Unremediated Material Weakness
summarizeSummary
Solitron Devices reported a strong Q3 with significant revenue and profit growth, alongside a 124% increase in backlog, despite a year-to-date decline in profitability and an ongoing material weakness in internal controls.
check_boxKey Events
-
Strong Q3 Financial Performance
For the three months ended November 30, 2025, net sales increased 49% to $5.02 million, gross profit rose 72% to $1.72 million, and net income surged 145% to $653,000 compared to the prior year period.
-
Significant Backlog Growth
Backlog as of November 30, 2025, increased 124% to $27.48 million, up from $12.28 million in the prior year, driven by a substantial AMRAAM program order.
-
COO Acquires Company Stock
The COO and President, Mark Matson, purchased 50,000 shares of company common stock for $725,000 at a price of $14.50 per share during the fiscal third quarter, demonstrating significant insider confidence.
-
Unremediated Material Weakness in Internal Controls
Management concluded that while new disclosure controls were designed, there was insufficient evidence to test their operating effectiveness to remediate the material weakness in internal control over financial reporting.
auto_awesomeAnalysis
Solitron Devices' third-quarter results show a significant operational turnaround, with substantial increases in net sales, gross profit, and net income. The impressive 124% growth in backlog to $27.48 million is a strong forward-looking indicator, suggesting robust future revenue. However, the year-to-date financial performance remains challenged, with a significant decline in net income and cash from operations compared to the prior year, indicating weak first two quarters. The continued disclosure of an unremediated material weakness in internal control over financial reporting is a persistent concern that investors should monitor. The COO's substantial stock purchase signals insider confidence, but the overall picture is mixed, with strong recent momentum and future prospects tempered by past performance and control issues.
At the time of this filing, SODI was trading at $20.15 on OTC in the Manufacturing sector, with a market capitalization of approximately $42.2M. The 52-week trading range was $14.00 to $21.50. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.